AUTOIMMUNE DISEASES AND ATHEROSCLEROSIS - PROBLEMS OF TREATMENT
The problem of comorbidity is one of the most important problems in clinical immunology. The commonest non-organ specific autoimmune diseases — rheumatoid arthritis (RA) and psoriasis are linked with accelerated atherosclerosis progression and increased cardiovascular risk. In autoimmune disorders a...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Scientific Сentre for Family Health and Human Reproduction Problems
2012-05-01
|
| Series: | Acta Biomedica Scientifica |
| Subjects: | |
| Online Access: | https://www.actabiomedica.ru/jour/article/view/952 |
| Summary: | The problem of comorbidity is one of the most important problems in clinical immunology. The commonest non-organ specific autoimmune diseases — rheumatoid arthritis (RA) and psoriasis are linked with accelerated atherosclerosis progression and increased cardiovascular risk. In autoimmune disorders associated with comorbidities the use of multitargeted drugs holds a promise. Examples of such drugs include the inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase (statins) and agonists of PPARα (fibrates) which exert antiinflammatory, immunomodulating, and anti-atherogenic activities. In this review we summarize our own research on statins and fibrates pre-clinical pharmacology, their efficacy and safety in patients with RA and psoriasis. |
|---|---|
| ISSN: | 2541-9420 2587-9596 |